Fulgent Genetics (FLGT) Other Working Capital Changes (2015 - 2026)

Fulgent Genetics has disclosed Other Working Capital Changes across 12 years of filings, most recently posting -$381000.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$381000.0, down 165.46% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (up 15.92% YoY), and the FY2025 annual result was -$1.6 million, up 56.91% from the prior year.
• Other Working Capital Changes came in at -$381000.0 for Q1 2026 at Fulgent Genetics, up from -$1.7 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $5.6 million in Q3 2023 to a low of -$8.7 million in Q4 2023.
• The 5-year median for Other Working Capital Changes is -$928000.0 (2025), against an average of -$993823.5.
• Across the five-year window, Other Working Capital Changes tumbled 479.6% in 2023 and soared 624.32% in 2025, its largest moves.
• Fulgent Genetics' Other Working Capital Changes stood at -$1.5 million in 2022, then sank by 479.6% to -$8.7 million in 2023, then surged by 50.0% to -$4.3 million in 2024, then soared by 60.89% to -$1.7 million in 2025, then soared by 77.59% to -$381000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$381000.0 (Q1 2026), -$1.7 million (Q4 2025), and $421000.0 (Q3 2025), per Business Quant data.